Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aytu Biopharma Inc
(NQ:
AYTU
)
2.715
UNCHANGED
Streaming Delayed Price
Updated: 3:47 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.715
Bid (Size)
2.660 (1)
Ask (Size)
2.990 (15)
Prev. Close
2.715
Today's Range
2.715 - 2.715
52wk Range
1.380 - 3.500
Shares Outstanding
5,567,490
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
April 03, 2024
Via
ACCESSWIRE
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
February 14, 2024
Via
ACCESSWIRE
Performance
YTD
-6.06%
-6.06%
1 Month
-11.13%
-11.13%
3 Month
-1.27%
-1.27%
6 Month
+3.63%
+3.63%
1 Year
+0.93%
+0.93%
More News
Read More
Earnings Scheduled For February 14, 2024
February 14, 2024
Via
Benzinga
Earnings Preview: Aytu BioPharma
February 13, 2024
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via
ACCESSWIRE
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
November 30, 2023
Via
ACCESSWIRE
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
November 14, 2023
Via
ACCESSWIRE
Aytu BioPharma's Earnings: A Preview
November 13, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
November 08, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 26, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 15, 2023
Via
Benzinga
Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28
September 28, 2023
Via
Investor Brand Network
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
September 26, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 07, 2023
Via
ACCESSWIRE
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
November 06, 2023
Via
Benzinga
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
October 09, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 27, 2023
Via
Benzinga
Earnings Outlook For Aytu BioPharma
September 26, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Via
Benzinga
Earnings Scheduled For September 27, 2023
September 27, 2023
Via
Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.